Imaging the placebo response: A neurofunctional review

European Neuropsychopharmacology

Volumn 18, Issue 7, 2008, Pages 473-485

  Faria, Vanda ^a   Fredrikson, Mats ^a   Furmark, Tomas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Functional magnetic resonance imaging; Neuroimaging; Placebo effect; Positron emission tomography; Review

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CAFFEINE; DOPAMINE; DOPAMINE RECEPTOR; FLUOXETINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE; PLACEBO; RACLOPRIDE; REMIFENTANIL; SEROTONIN; SODIUM CHLORIDE;

ACUPUNCTURE ANALGESIA; ANALGESIA; BRAIN METABOLISM; BRAIN REGION; CINGULATE GYRUS; COGNITION; DEPRESSION; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ELECTROENCEPHALOGRAM; EXPECTATION; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE METABOLISM; HEMODYNAMICS; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NERVE CELL NETWORK; NERVE STIMULATION; NEUROIMAGING; NEUROTRANSMISSION; PAIN; PAIN ASSESSMENT; PARKINSON DISEASE; PLACEBO EFFECT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TRANQUILIZING ACTIVITY;

BRAIN; HUMANS; IMMUNOLOGIC TESTS; NERVOUS SYSTEM DISEASES; PLACEBO EFFECT; PLACEBOS;

EID: 44349112877     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.03.002     Document Type: Review

References (102)

1. Allman J.M., Hakeem A., Erwin J.M., Nimchinsky E., and Hof P. The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann. N. Y. Acad. Sci. 935 (2001) 107-117
2. Altier N., and Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci. 65 22 (1999) 2269-2287
3. Amanzio M., and Benedetti F. Neuropharmacological dissection of placebo analgesia: Expectation-activated opioid systems versus conditioning-activated specific subsystems. J. Neurosci. 19 1 (1999) 484-494
4. Bausell R.B., Lao L., Bergman S., Lee W.L., and Berman B.M. Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials. Eval. Health Prof. 28 1 (2005) 9-26
5. Beecher H.K. The powerful placebo. J. Am. Med. Assoc. 159 17 (1955) 1602-1606
6. Benedetti F. The importance of considering the effects of perceived group assignment in placebo-controlled trials. Eval. Health Prof. 28 1 (2005) 5-6
7. Benedetti F., Arduino C., and Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J. Neurosci. 19 9 (1999) 3639-3648
8. Benedetti F., Arduino C., Costa S., Vighetti S., Tarenzi L., Rainero I., and Asteggiano G. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain 121 1-2 (2006) 133-144
9. Benedetti F., Colloca L., Torre E., Lanotte M., Melcarne A., Pesare M., Bergamasco B., and Lopiano L. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat. Neurosci. 7 6 (2004) 587-588
10. Benedetti F., Mayberg H.S., Wager T.D., Stohler C.S., and Zubieta J.K. Neurobiological mechanisms of the placebo effect. J. Neurosci. 25 45 (2005) 10390-10402
11. Benedetti F., Pollo A., Lopiano L., Lanotte M., Vighetti S., and Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J. Neurosci. 23 10 (2003) 4315-4323
12. Berman S.M., Chang L., Suyenobu B., Derbyshire S.W., Stains J., Fitzgerald L., Mandelkern M., Hamm L., Vogt B., Naliboff B.D., and Mayer E.A. Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist alosetron. Gastroenterology 123 4 (2002) 969-977
13. Bingel U., Lorenz J., Schoell E., Weiller C., and Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120 1-2 (2006) 8-15
14. 11C] raclopride study with amphetamine. J. Neurosci. 27 15 (2007) 3998-4003
15. Bush G., Frazier J.A., Rauch S.L., Seidman L.J., Whalen P.J., Jenike M.A., Rosen B.R., and Biederman J. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol. Psychiatry 45 12 (1999) 1542-1552
16. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn. Sci. 4 6 (2000) 215-222
17. Colloca L., and Benedetti F. Placebos and painkillers: is mind as real as matter?. Nat. Rev. Neurosci. 6 7 (2005) 545-552
18. de la Fuente-Fernández R. Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease. Parkinsonism Relat. Disord. 10 3 (2004) 125-127
19. de la Fuente-Fernández R., Lidstone S., and Stoessl A.J. Placebo effect and dopamine release. J. Neural. Transm. Suppl. 70 (2006) 415-418
20. de la Fuente-Fernández R., Phillips A.G., Zamburlini M., Sossi V., Calne D.B., Ruth T.J., and Stoessl A.J. Dopamine release in human ventral striatum and expectation of reward. Behav. Brain Res. 136 2 (2002) 359-363
21. de la Fuente-Fernández R., Ruth T.J., Sossi V., Schulzer M., Calne D.B., and Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293 5532 (2001) 1164-1166
22. de la Fuente-Fernandez R., and Stoessl A.J. The biochemical bases of the placebo effect. Sci. Eng. Ethics 10 1 (2004) 143-150
23. de la Fuente-Fernández R., and Stoessl A.J. The biochemical bases for reward. Implications for the placebo effect. Eval. Health Prof. 25 4 (2002) 387-398
24. deCharms R.C., Maeda F., Glover G.H., Ludlow D., Pauly J.M., Soneji D., Gabrieli J.D., and Mackey S.C. Control over brain activation and pain learned by using real-time functional MRI. Proc. Natl. Acad. Sci. U. S. A. 102 51 (2005) 18626-18631
25. Devinsky O., Morrell M.J., and Vogt B.A. Contributions of anterior cingulate cortex to behaviour. Brain 118 Pt 1 (1995) 279-306
26. Ernst M., Nelson E.E., McClure E.B., Monk C.S., Munson S., Eshel N., Zarahn E., Leibenluft E., Zametkin A., Towbin K., Blair J., Charney D., and Pine D.S. Choice selection and reward anticipation: an fMRI study. Neuropsychologia 42 12 (2004) 1585-1597
27. Fairhurst M., Wiech K., Dunckley P., and Tracey I. Anticipatory brainstem activity predicts neural processing of pain in humans. Pain 128 1-2 (2007) 101-110
28. Fields H. State-dependent opioid control of pain. Nat. Rev. Neurosci. 5 7 (2004) 565-575
29. Finniss D.G., and Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 114 1-2 (2005) 3-6
30. Foltz E.L., and White Jr. L.E. Pain "relief" by frontal cingulumotomy. J. Neurosurg. 19 (1962) 89-100
31. Fuster J.M. The prefrontal cortex-an update: time is of the essence. Neuron 30 2 (2001) 319-333
32. Haour F. Mechanisms of the placebo effect and of conditioning. Neuroimmunomodulation 12 4 (2005) 195-200
33. He S.Q., Dum R.P., and Strick P.L. Topographic organization of corticospinal projections from the frontal lobe: motor areas on the medial surface of the hemisphere. J. Neurosci. 15 5 Pt 1 (1995) 3284-3306
34. Hoffman G.A., Harrington A., and Fields H.L. Pain and the placebo: what we have learned. Perspect. Biol. Med. 48 2 (2005) 248-265
35. Holroyd C.B., and Coles M.G. The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol. Rev. 109 4 (2002) 679-709
36. Hrobjartsson A., and Gotzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N. Engl. J. Med. 344 21 (2001) 1594-1602
37. Hrobjartsson A., and Gotzsche P.C. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J. Intern. Med. 256 2 (2004) 91-100
38. Hunter A.M., Leuchter A.F., Morgan M.L., and Cook I.A. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am. J. Psychiatry 163 8 (2006) 1426-1432
39. Kaasinen V., Aalto S., Nagren K., and Rinne J.O. Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport 15 2 (2004) 281-285
40. Kaasinen V., Aalto S., Nagren K., and Rinne J.O. Expectation of caffeine induces dopaminergic responses in humans. Eur. J. Neurosci. 19 8 (2004) 2352-2356
41. Kaptchuk T.J. Acupuncture: theory, efficacy, and practice. Ann. Intern. Med. 136 5 (2002) 374-383
42. Kennerley S.W., Walton M.E., Behrens T.E., Buckley M.J., and Rushworth M.F. Optimal decision making and the anterior cingulate cortex. Nat. Neurosci. 9 7 (2006) 940-947
43. Kienle G.S., and Kiene H. Placebo effect and placebo concept: a critical methodological and conceptual analysis of reports on the magnitude of the placebo effect. Altern. Ther. Health Med. 2 6 (1996) 39-54
44. Kienle G.S., and Kiene H. The powerful placebo effect: fact or fiction?. J. Clin. Epidemiol. 50 12 (1997) 1311-1318
45. Komura Y., Tamura R., Uwano T., Nishijo H., Kaga K., and Ono T. Retrospective and prospective coding for predicted reward in the sensory thalamus. Nature 412 6846 (2001) 546-549
46. Kong J., Gollub R.L., Rosman I.S., Webb J.M., Vangel M.G., Kirsch I., and Kaptchuk T.J. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J. Neurosci. 26 2 (2006) 381-388
47. Koshi E.B., and Short C.A. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract. 7 1 (2007) 4-20
48. Koyama T., Tanaka Y.Z., and Mikami A. Nociceptive neurons in the macaque anterior cingulate activate during anticipation of pain. Neuroreport 9 11 (1998) 2663-2667
49. Kupers R., Maeyaert J., Boly M., Faymonville M.E., and Laureys S. Naloxone-insensitive epidural placebo analgesia in a chronic pain patient. Anesthesiology 106 6 (2007) 1239-1242
50. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., and Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am. J. Psychiatry 159 1 (2002) 122-129
51. Levine J.D., Gordon N.C., and Fields H.L. The mechanism of placebo analgesia. Lancet 2 8091 (1978) 654-657
52. Lieberman M.D. Reflective and reflexive judgment processes: a social cognitive neuroscience approach. In: Forgas J.P., Williams K.R., and von Hippel W. (Eds). Social Judgments: Explicit and Implicit Processes (2003), Cambridge University Press, New York 44-67
53. Lieberman M.D., Jarcho J.M., Berman S., Naliboff B.D., Suyenobu B.Y., Mandelkern M., and Mayer E.A. The neural correlates of placebo effects: a disruption account. Neuroimage 22 1 (2004) 447-455
54. Macedo A., Farre M., and Banos J.E. Placebo effect and placebos: what are we talking about? Some conceptual and historical considerations. Eur. J. Clin. Pharmacol. 59 4 (2003) 337-342
55. Martikainen I.K., Hagelberg N., Mansikka H., Hietala J., Nagren K., Scheinin H., and Pertovaara A. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia. Neurosci. Lett. 376 3 (2005) 149-153
56. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., and Jerabek P.A. The functional neuroanatomy of the placebo effect. Am. J. Psychiatry 159 5 (2002) 728-737
57. McRae C., Cherin E., Yamazaki T.G., Diem G., Vo A.H., Russell D., Ellgring J.H., Fahn S., Greene P., Dillon S., Winfield H., Bjugstad K.B., and Freed C.R. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Arch. Gen. Psychiatry 61 4 (2004) 412-420
58. Mercado R., Constantoyannis C., Mandat T., Kumar A., Schulzer M., Stoessl A.J., and Honey C.R. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation. Mov. Disord. 21 9 (2006) 1457-1461
59. Miller B.T., and D'Esposito M. Searching for "the top" in top-down control. Neuron 48 4 (2005) 535-538
60. Montgomery G.H., and Kirsch I. Classical conditioning and the placebo effect. Pain 72 1-2 (1997) 107-113
61. Nemoto H., Nemoto Y., Toda H., Mikuni M., and Fukuyama H. Placebo analgesia: a PET study. Exp. Brain Res. 179 4 (2007) 655-664
62. O'Doherty J.P., Deichmann R., Critchley H.D., and Dolan R.J. Neural responses during anticipation of a primary taste reward. Neuron 33 5 (2002) 815-826
63. Pariente J., White P., Frackowiak R.S., and Lewith G. Expectancy and belief modulate the neuronal substrates of pain treated by acupuncture. Neuroimage 25 4 (2005) 1161-1167
64. Petrovic P., Dietrich T., Fransson P., Andersson J., Carlsson K., and Ingvar M. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron 46 6 (2005) 957-969
65. Petrovic P., Kalso E., Petersson K.M., and Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science 295 5560 (2002) 1737-1740
66. Peyron R., Laurent B., and Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol. Clin. 30 5 (2000) 263-288
67. Ploghaus A., Becerra L., Borras C., and Borsook D. Neural circuitry underlying pain modulation: expectation, hypnosis, placebo. Trends Cogn. Sci. 7 5 (2003) 197-200
68. Pollo A., Torre E., Lopiano L., Rizzone M., Lanotte M., Cavanna A., Bergamasco B., and Benedetti F. Expectation modulates the response to subthalamic nucleus stimulation in parkinsonian patients. Neuroreport 13 11 (2002) 1383-1386
69. Portas C.M., Rees G., Howseman A.M., Josephs O., Turner R., and Frith C.D. A specific role for the thalamus in mediating the interaction of attention and arousal in humans. J. Neurosci. 18 21 (1998) 8979-8989
70. Price D.D. Psychological Mechanisms of Pain and Analgesia (1999), IASP Press, Seattle
71. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science 288 5472 (2000) 1769-1772
72. Price D.D. Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol. Interv. 2 6 (2002) 392-403 339
73. Price D.D., Craggs J., Verne G.N., Perlstein W.M., and Robinson M.E. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 127 1-2 (2007) 63-72
74. Radin D., and Lobach E. Toward understanding the placebo effect: investigating a possible retrocausal factor. J. Altern. Complement. Med. 13 7 (2007) 733-740
75. Rainville P., and Duncan G.H. Functional brain imaging of placebo analgesia: methodological challenges and recommendations. Pain 121 3 (2006) 177-180
76. Rainville P., Duncan G.H., Price D.D., Carrier B., and Bushnell M.C. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 277 5328 (1997) 968-971
77. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 80 1 (1998) 1-27
78. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., and Zubieta J.K. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55 2 (2007) 325-336
79. Shapiro A.K., and Shapiro E. The Powerful Placebo: from Ancient Priest to Modern Physician (1997), The Johns Hopkins University Press, London
80. Singer T., Seymour B., O'Doherty J., Kaube H., Dolan R.J., and Frith C.D. Empathy for pain involves the affective but not sensory components of pain. Science 303 5661 (2004) 1157-1162
81. Sprenger T., Berthele A., Platzer S., Boecker H., and Tolle T.R. What to learn from in vivo opioidergic brain imaging?. Eur. J. Pain 9 2 (2005) 117-121
82. Stewart-Williams S., and Podd J. The placebo effect: dissolving the expectancy versus conditioning debate. Psychol. Bull. 130 2 (2004) 324-340
83. Strafella A.P., Ko J.H., and Monchi O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Neuroimage 31 4 (2006) 1666-1672
84. Tracey I., and Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 55 3 (2007) 377-391
85. Vase L., Robinson M.E., Verne G.N., and Price D.D. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 105 1-2 (2003) 17-25
86. Vase L., Robinson M.E., Verne G.N., and Price D.D. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115 3 (2005) 338-347
87. Vogt B.A., Derbyshire S., and Jones A.K. Pain processing in four regions of human cingulate cortex localized with co-registered PET and MR imaging. Eur. J. Neurosci. 8 7 (1996) 1461-1473
88. Vogt B.A., Finch D.M., and Olson C.R. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb. Cortex 2 6 (1992) 435-443
89. Volkow N.D., Wang G.J., Ma Y., Fowler J.S., Wong C., Jayne M., Telang F., and Swanson J.M. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage 32 4 (2006) 1782-1792
90. Volkow N.D., Wang G.J., Ma Y., Fowler J.S., Zhu W., Maynard L., Telang F., Vaska P., Ding Y.S., Wong C., and Swanson J.M. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J. Neurosci. 23 36 (2003) 11461-11468
91. Wager T.D., Matre D., and Casey K.L. Placebo effects in laser-evoked pain potentials. Brain Behav. Immun. 20 3 (2006) 219-230
92. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., Kosslyn S.M., Rose R.M., and Cohen J.D. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303 5661 (2004) 1162-1167
93. Wager T.D., Scott D.J., and Zubieta J.K. Placebo effects on human {micro}-opioid activity during pain. Proc. Natl. Acad. Sci. U.S.A. 104 26 (2007) 11056-11061
94. Watson A., El-Deredy W., Vogt B.A., and Jones A.K. Placebo analgesia is not due to compliance or habituation: EEG and behavioural evidence. Neuroreport 18 8 (2007) 771-775
95. Wolf S. Effects of suggestion and conditioning on the action of chemical agents in human subjects: the pharmacology of placebos. J. Clin. Invest. 29 1 (1950) 100-109
96. Wolf S. The pharmacology of placebos. Pharmacol. Rev. 11 (1959) 689-704
97. Wood P.B. Mesolimbic dopaminergic mechanisms and pain control. Pain 120 3 (2006) 230-234
98. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 284 23 (2000) 3043-3045
99. Wu M.T., Sheen J.M., Chuang K.H., Yang P., Chin S.L., Tsai C.Y., Chen C.J., Liao J.R., Lai P.H., Chu K.A., Pan H.B., and Yang C.F. Neuronal specificity of acupuncture response: a fMRI study with electroacupuncture. Neuroimage 16 4 (2002) 1028-1037
100. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., Nichols T.E., and Stohler C.S. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J. Neurosci. 25 34 (2005) 7754-7762
101. Zubieta J.K., Ketter T.A., Bueller J.A., Xu Y., Kilbourn M.R., Young E.A., and Koeppe R.A. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch. Gen. Psychiatry 60 11 (2003) 1145-1153
102. Zubieta J.K., Yau W.Y., Scott D.J., and Stohler C.S. Belief or need? Accounting for individual variations in the neurochemistry of the placebo effect. Brain Behav. Immun. 20 1 (2006) 15-26